Biovica International
14.9.2021 08:21:37 CEST | ACCESS Newswire | Press release
UPPSALA, SE / ACCESSWIRE / September 14, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)
Biovica, active in cancer diagnostics, today announces that DiviTumTKa results from the large BioItaLEE study will be presented as a poster during the European Society for Medical Oncology (ESMO) meeting 16 to 21 September 2021. The results strengthen the potential of DiviTum ® TKa as a treatment monitoring devise for CDK4/6 inhibitor treatments.
The results from a large independent study with a CDK4/6 inhibitor therapy and DiviTum ® TKa as a treatment monitoring assay in 287 patients with metastatic breast cancer is presented at the ESMO congress.
"I'm happy to see that the presented results on this CDK4/6 inhibitor ribociclib are consistent with earlier CDK4/6-results for example for palbociclib. The study results are highly encouraging as a reference for using DiviTum®TKa for the monitoring of CDK4/6 inhibitor treatments in HR positive metastatic breast cancer," said Anders Rylander, CEO of Biovica.
The study concludes that TKa appears to be a new promising prognostic, predictive and monitoring biomarker in patients with HR positive/HER2 negative metastatic breast cancer treated with ribociclib plus letrozole as first-line therapy. Baseline and dynamic TKa changes provided independent valuable information. Lack of TKa suppression at day 15 indicates enrichment for primary resistance and poor prognosis. TKa rebound at treatment cycle 2, day 1 may indicate early adaptation to ribociclib plus letrozole, while persistent suppression seems to identify patients with sustained inhibition and excellent prognosis.
Link to poster: https://cslide.ctimeetingtech.com/esmo2021/attendee/confcal_4/presentation/list?q=292P+-+
Contact
Anders Rylander, CEO
Phone: +46-18-444 48 35
E-mail: anders.rylander@biovica.com
Biovica - Treatment decisions with greater confidence
Biovica develops and commercializes blood-based biomarker assays to evaluate efficacy of cancer treatments. Biovica's assay DiviTum ® measure cell proliferation by detecting a biomarker in the blood stream. The assay has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. The first application for DiviTum is monitoring of treatment for patients with metastatic breast cancer. Biovica's vision is that all cancer patients will get an optimal treatment from day one. Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum is CE-marked and registered with the Swedish Medical Products Agency. Biovica's shares are traded on the Nasdaq First North Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser, info@fnca.se , +46 8 528 00 399. For more information please visit: www.biovica.com .
Attachments
Promising DiviTumTKa results from BioItaLEE study presented at ESMO
SOURCE: Biovica International
View source version on accesswire.com:
https://www.accesswire.com/663954/Promising-DiviTumTKa-Results-from-BioItaLEE-Study-Presented-at-ESMO
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Masterminds Education Named "Most Nurturing Early Education Environment" at UAE Business Awards 2026; Standardizes Early Learning Model with 12-Student Class Cap Structured as Two Learning Groups of Six20.2.2026 08:35:00 CET | Press release
Dubai-based provider marks 10 consecutive years of recognition and reinforces a whole-child program delivered through ultra-small learning groups DUBAI, AE / ACCESS Newswire / February 20, 2026 / Masterminds Education announced today that it has been recognized at the UAE Business Awards 2026 with two honors: Most Nurturing Early Education Environment 2026 and Child Development Excellence Award 2026. The awards extend Masterminds' record of 10 consecutive years of recognition and reinforce the organization's focus on high-impact early education built on consistency, relationships, and outcomes. As part of strengthening the operating conditions behind the "Most Nurturing" recognition, Masterminds Early Learning Center in Dubai announced an optimization to its early education structure: beginning in the 2026-27 academic year, the Early Learning Center will operate with a maximum class size of 12 students across Preschool through KG2, organized as two learning groups of six within each cl
Polaris Renewable Energy Announces Q4 and Annual 2025 Results19.2.2026 13:50:00 CET | Press release
TORONTO, ONTARIO / ACCESS Newswire / February 19, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the year ended December 31, 2025. This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise. HIGHLIGHTS For the quarter ended December 31, 2025 consolidated energy production increased by 1% when compared to the same quarter in 2024, while annual consolidated energy production was 810,731 MWh for the year ended December 31, 2025 versus 764,756 for the year ended December 31, 2024. The Company generated $80.5 million in revenue for the year ended December 31, 2025, compared to $75.8 million in the same pe
Honoring Nelson Mandela's Legacy of Financial Empowerment and Inclusion19.2.2026 13:47:00 CET | Press release
Datavault AI and Nelson Mandela Family Members, Re Mandela Dlamini & Manaway L.L.C., Announce Formation of Mandela Digital Ventures to Develop Digital Asset Products Aligned with the Legacy of Nelson Mandela PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 19, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, and Mandela Dlamini & Manaway L.L.C., a Wyoming based organization dedicated to perpetuating Nelson Mandela's vision of equality and human dignity, today announced a strategic joint venture, Mandela Digital Ventures to develop and launch a new suite of digital asset products. The collaboration will create blockchain-based financial tools and assets, designed to drive financial inclusion for underserved populations worldwide. These products will directly reflect the enduring values of Nelson Mandela: freedom, justice, reconciliation,
From Seoul's Global K-Wave to Web3 Leadership: Datavault AI and TBURN Chain Align K-Pop, Esports, and Korean Cultural Exports with Enterprise-Grade Data Asset Infrastructure and Tokenized Real World Assets18.2.2026 13:00:00 CET | Press release
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 18, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today announced the execution of a collaboration agreement with TBURN Chain Foundation ("TBURN"), a high-performance blockchain infrastructure platform. The agreement establishes a strategic framework to explore integration of Datavault's data asset tokenization, valuation, and Information Data Exchange® (IDE) technologies with TBURN's high-throughput blockchain network, which is designed to support enterprise-scale transaction processing and near-instant settlement. TBURN is engaged across global esports and entertainment ecosystems, including partnerships involving esports champion Faker and K-Pop acts such as BLACKPINK, providing potential pathways for authenticated digital engagement and data-driven monetization models. Originating f
The Numbers are Clear: Latest Iteration of Stagwell's News Advertising Study Shows Germans Love Their News18.2.2026 11:00:00 CET | Press release
Stagwell, Axel Springer, Teads and The Trade Desk partner on German News Advertising Study, drawing insights from over 11,000 respondents Study finds the proportion of ‘news junkies' in Germany is highest of all the surveyed markets BERLIN, GERMANY / ACCESS Newswire / February 18, 2026 / Stagwell, the global challenger network transforming marketing through AI, released the latest installment of its News Advertising Study in partnership with Axel Springer, Teads and The Trade Desk. The survey, fielded among 11,282 adults in Germany, builds on Stagwell's prior News Advertising studies conducted in Asia Pacific, Canada, the U.S. and UK. This regional study further reinforces it is safe for brands to advertise adjacent to quality news content agnostic of the topic. "The Future of News research for the German market illustrates how important it is for brands to advertise in quality news publications. Germany has a 10-percentage point higher share of news enthusiasts than other markets, and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom